Selected research
Industry Growth & Trends
Global Genetic Disease Diagnostic Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Genetic Disease Diagnostic market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Genetic Disease Diagnostic is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Genetic Disease Diagnostic is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Genetic Disease Diagnostic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Genetic Disease Diagnostic market include Abbott, PerkinElmer, Roche Diagnostics, Bio Rad, Thermo Fisher Scientific, BGI Group, Berry Genomics, Da An Gene Co., Ltd. and Illumina, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Genetic Disease Diagnostic market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Genetic Disease Diagnostic market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Genetic Disease Diagnostic market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Genetic Disease Diagnostic.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Genetic Disease Diagnostic market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Genetic Disease Diagnostic Market by Company
Abbott
PerkinElmer
Roche Diagnostics
Bio Rad
Thermo Fisher Scientific
BGI Group
Berry Genomics
Da An Gene Co., Ltd.
Illumina
CapitalBio Technology
Genetic Disease Diagnostic Segment by Type
Prenatal Diagnosis
Screening for Single Gene Genetic Disease
Preimplantation Genetic Testing
Others
Genetic Disease Diagnostic Segment by Application
Hospital
Medical Laboratory
Others
Genetic Disease Diagnostic Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetic Disease Diagnostic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Genetic Disease Diagnostic and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetic Disease Diagnostic.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Genetic Disease Diagnostic companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Prenatal Diagnosis
- Screening for Single Gene Genetic Disease
- Preimplantation Genetic Testing
- Others
Applications
- Hospital
- Medical Laboratory
- Others
Companies covered
- Abbott
- PerkinElmer
- Roche Diagnostics
- Bio Rad
- Thermo Fisher Scientific
- BGI Group
- Berry Genomics
- Da An Gene Co., Ltd.
- Illumina
- CapitalBio Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Genetic Disease Diagnostic Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Genetic Disease Diagnostic Market Size by Region (2021-2032)
- 1.4.1 Global Genetic Disease Diagnostic Market Size by Region (2021-2026)
- 1.4.2 Global Genetic Disease Diagnostic Market Size by Region (2027-2032)
- 1.5 Key Regions Genetic Disease Diagnostic Market Size (2021-2032)
- 1.5.1 North America Genetic Disease Diagnostic Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Genetic Disease Diagnostic Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Genetic Disease Diagnostic Market Size Growth Rate (2021-2032)
- 1.5.4 South America Genetic Disease Diagnostic Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Genetic Disease Diagnostic Market Size Growth Rate (2021-2032)
2 Genetic Disease Diagnostic Market by Type
- 2.1 Type Introduction
- 2.1.1 Prenatal Diagnosis
- 2.1.2 Screening for Single Gene Genetic Disease
- 2.1.3 Preimplantation Genetic Testing
- 2.1.4 Others
- 2.2 Global Genetic Disease Diagnostic Market Size by Type
- 2.2.1 Global Genetic Disease Diagnostic Market Size Overview by Type (2021-2032)
- 2.2.2 Global Genetic Disease Diagnostic Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Genetic Disease Diagnostic Market Size Forecasted by Type (2027-2032)
- 2.3 Global Genetic Disease Diagnostic Market Size by Regions
- 2.3.1 North America Genetic Disease Diagnostic Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Genetic Disease Diagnostic Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Genetic Disease Diagnostic Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Genetic Disease Diagnostic Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Genetic Disease Diagnostic Market Size Breakdown by Type (2021-2026)
3 Genetic Disease Diagnostic Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Medical Laboratory
- 3.1.3 Others
- 3.2 Global Genetic Disease Diagnostic Market Size by Application
- 3.2.1 Global Genetic Disease Diagnostic Market Size Overview by Application (2021-2032)
- 3.2.2 Global Genetic Disease Diagnostic Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Genetic Disease Diagnostic Market Size Forecasted by Application (2027-2032)
- 3.3 Global Genetic Disease Diagnostic Market Size by Regions
- 3.3.1 North America Genetic Disease Diagnostic Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Genetic Disease Diagnostic Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Genetic Disease Diagnostic Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Genetic Disease Diagnostic Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Genetic Disease Diagnostic Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Genetic Disease Diagnostic Industry Trends
- 4.2 Genetic Disease Diagnostic Industry Drivers
- 4.3 Genetic Disease Diagnostic Industry Opportunities and Challenges
- 4.4 Genetic Disease Diagnostic Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Genetic Disease Diagnostic Revenue (2021-2026)
- 5.2 Global Genetic Disease Diagnostic Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Genetic Disease Diagnostic Key Company Headquarters & Area Served
- 5.4 Global Genetic Disease Diagnostic Company, Product Type & Application
- 5.5 Global Genetic Disease Diagnostic Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Genetic Disease Diagnostic Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Genetic Disease Diagnostic Players Market Share by Revenue in 2025
- 5.6.3 2025 Genetic Disease Diagnostic Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Abbott
- 6.1.1 Abbott Company Information
- 6.1.2 Abbott Business Overview
- 6.1.3 Abbott Genetic Disease Diagnostic Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Abbott Genetic Disease Diagnostic Product Portfolio
- 6.1.5 Abbott Recent Developments
- 6.2 PerkinElmer
- 6.2.1 PerkinElmer Company Information
- 6.2.2 PerkinElmer Business Overview
- 6.2.3 PerkinElmer Genetic Disease Diagnostic Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 PerkinElmer Genetic Disease Diagnostic Product Portfolio
- 6.2.5 PerkinElmer Recent Developments
- 6.3 Roche Diagnostics
- 6.3.1 Roche Diagnostics Company Information
- 6.3.2 Roche Diagnostics Business Overview
- 6.3.3 Roche Diagnostics Genetic Disease Diagnostic Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Roche Diagnostics Genetic Disease Diagnostic Product Portfolio
- 6.3.5 Roche Diagnostics Recent Developments
- 6.4 Bio Rad
- 6.4.1 Bio Rad Company Information
- 6.4.2 Bio Rad Business Overview
- 6.4.3 Bio Rad Genetic Disease Diagnostic Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Bio Rad Genetic Disease Diagnostic Product Portfolio
- 6.4.5 Bio Rad Recent Developments
- 6.5 Thermo Fisher Scientific
- 6.5.1 Thermo Fisher Scientific Company Information
- 6.5.2 Thermo Fisher Scientific Business Overview
- 6.5.3 Thermo Fisher Scientific Genetic Disease Diagnostic Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Thermo Fisher Scientific Genetic Disease Diagnostic Product Portfolio
- 6.5.5 Thermo Fisher Scientific Recent Developments
- 6.6 BGI Group
- 6.6.1 BGI Group Company Information
- 6.6.2 BGI Group Business Overview
- 6.6.3 BGI Group Genetic Disease Diagnostic Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 BGI Group Genetic Disease Diagnostic Product Portfolio
- 6.6.5 BGI Group Recent Developments
- 6.7 Berry Genomics
- 6.7.1 Berry Genomics Company Information
- 6.7.2 Berry Genomics Business Overview
- 6.7.3 Berry Genomics Genetic Disease Diagnostic Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Berry Genomics Genetic Disease Diagnostic Product Portfolio
- 6.7.5 Berry Genomics Recent Developments
- 6.8 Da An Gene Co., Ltd.
- 6.8.1 Da An Gene Co., Ltd. Company Information
- 6.8.2 Da An Gene Co., Ltd. Business Overview
- 6.8.3 Da An Gene Co., Ltd. Genetic Disease Diagnostic Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Da An Gene Co., Ltd. Genetic Disease Diagnostic Product Portfolio
- 6.8.5 Da An Gene Co., Ltd. Recent Developments
- 6.9 Illumina
- 6.9.1 Illumina Company Information
- 6.9.2 Illumina Business Overview
- 6.9.3 Illumina Genetic Disease Diagnostic Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Illumina Genetic Disease Diagnostic Product Portfolio
- 6.9.5 Illumina Recent Developments
- 6.10 CapitalBio Technology
- 6.10.1 CapitalBio Technology Company Information
- 6.10.2 CapitalBio Technology Business Overview
- 6.10.3 CapitalBio Technology Genetic Disease Diagnostic Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 CapitalBio Technology Genetic Disease Diagnostic Product Portfolio
- 6.10.5 CapitalBio Technology Recent Developments
7 North America
- 7.1 North America Genetic Disease Diagnostic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Genetic Disease Diagnostic Market Size by Country (2021-2026)
- 7.3 North America Genetic Disease Diagnostic Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Genetic Disease Diagnostic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Genetic Disease Diagnostic Market Size by Country (2021-2026)
- 8.3 Europe Genetic Disease Diagnostic Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Genetic Disease Diagnostic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Genetic Disease Diagnostic Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Genetic Disease Diagnostic Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Genetic Disease Diagnostic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Genetic Disease Diagnostic Market Size by Country (2021-2026)
- 10.3 South America Genetic Disease Diagnostic Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Genetic Disease Diagnostic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Genetic Disease Diagnostic Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Genetic Disease Diagnostic Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst